Off the wire
• China urges Britain to stop interfering in HK affairs  • 1st LD Writethru: Scottish gov't to publish second independence referendum bill for consultation next week  • Weather forecast for major Chinese cities, regions -- Oct.13  • Weather forecast for world cities -- Oct. 13  • U.S. bank CEO resigns amid fake accounts scandal  • WTA Tianjin Open results  • Spotlight: China, Portuguese-speaking countries seek "fast lane" for trade  • 3rd LD Writethru: Nigeria confirms release of 21 Chibok girls  • Feature: Admiration for Olympic stars causes change in rural Uganda  • 1st Ld-Writethru: China FDI inflow rises 1.2 pct in Sept.  
You are here: 　 Home

Japan's Fujifilm to invest in China Resources Pharmaceutical Group

Xinhua, October 13, 2016 Adjust font size:

Fujifilm Corporation, a Japanese maker of photographic films, digital cameras and medical systems, announced Thursday that it has reached an agreement to subscribe for ordinary shares worth HK$820 million (106 million U.S. dollars) in China Resources Pharmaceutical Group Limited.

The purchase will take place in the Chinese drug maker's planned initial public offering and new listing on the Main Board of the Hong Kong Stock Exchange.

Through the acquisition of shares, Fujifilm aims to expand its healthcare business in China, including pharmaceuticals and dietary supplements, regenerative medicine and medical devices, said the Japanese company.

Fujifilm, headquartered in Tokyo, has been operating healthcare business in China for medical diagnosis systems and services including X-ray diagnostic imaging devices, endoscopes and medical IT. Endit